SEO for Medical Weight Loss Clinics: Which GLP-1 and Ozempic Keywords Are Worth Ranking For

Medical weight loss SEO is mostly a sorting problem. GLP-1 keywords fall into classes, and each class has a different winner. Brand-name drug searches are owned by large consumer health publishers, local drug-plus-city searches are contested by clinics and directories, and aftercare questions are the class to test next. Rank for the classes you can win, build the right page type for each, and keep every claim on the page inside what the FDA and FTC support.

The mistake I see most often is a clinic building its site around "Ozempic" because that is the biggest name in the news. The people typing that word are mostly reading, and the publishers they are reading already exist.

This guide sorts the keyword classes, assigns a page to each, covers the compliance lines on page copy, and ends with a build order.

For the clinic-wide plan, see the weight loss clinic marketing guide.

Differentiation lives in the GLP-1 era playbook.

Key Takeaways

• Sort GLP-1 keywords into six classes before you write a page. Each class has a different competitor set and page type.
• Brand-name drug informational searches such as "Ozempic for weight loss" return consumer health publishers and drug information sites, so a clinic page is a poor use of effort there.
• Local searches that pair a drug or program with a city return clinic pages and directories, which is where an independent clinic can compete.
• Aftercare and continuation questions fit a clinician's authority, so they are worth building early and checking against the live SERP.
• Compounded medication pages are the highest-risk content. FDA says compounded drugs are not FDA approved and flags claims that a compounded drug is the same as an approved one.
• Authorship and sourcing carry weight in a health topic. Google says it gives extra weight to strong E-E-A-T on topics that could significantly impact health.

The Six Keyword Classes in Medical Weight Loss SEO

Keyword class is my working term for a group of searches that share one searcher intent and one set of ranking competitors.

Every GLP-1 query a clinic cares about belongs to one of these classes. I sorted them by checking what ranks today for classes A, B, and C. The SERP evidence is in the notes below the table, and classes D to F still need a live check.

What I saw in the SERPs. A search for "ozempic for weight loss" returned consumer health publishers (Livestrong, Choosing Therapy, Drugs.com) and similar informational pages, with no independent clinic page in sight. Another, for "weight loss clinic near me semaglutide tirzepatide Denver," returned clinic pages, urgent care location pages, and several third-party directories. The query "SEO for medical weight loss" returned agency pages of roughly 1,000 words, with no outbound citations on the one I opened.

Those are my free-data checks from October 28, 2026, and they do not replace volume and difficulty data from a keyword tool. They tell you who you will be standing next to.

Why Class A is a trap

Based on three snippet-level searches as of October 28, 2026, a clinic page can be accurate and still lose, because the SERP looks like a publisher contest. The reader on that SERP is also researching a drug, not a provider. The better play is to answer the connected questions inside your own content. Examples are brand versus generic, which medication a clinician selects, and what monitoring looks like. Let those pages feed your local pages.

Where Class B and C win

Local drug-plus-city and program searches are where the patient is choosing a provider. The competitors there are other clinics, and a clinic with a real clinician, real location signals, and a sourced page can beat them. The local rank checker shows where you stand on the map for these terms.

Build Each Page Type Right

The location service page (Class B)

Each location gets its own page covering the medication, the supervised program, and the local logistics.

• Lead with the answer, covering what the program is, who it is for, and how a visit works.
• State eligibility the way the current label does. FDA's original approvals set the weight-management thresholds. They covered adults with obesity (BMI of 30 or more) or overweight (BMI of 27 or more) with at least one weight-related condition. Both were used with a reduced-calorie diet and increased physical activity (Wegovy, June 2021; Zepbound, November 2023). The current labels list more. Wegovy's prescribing information, which I opened (revised 03/2026), also covers reducing cardiovascular risk in adults with established disease and obesity or overweight, pediatric patients aged 12 and older with obesity, and noncirrhotic MASH in adults. Zepbound's prescribing information (revised 08/2026) also covers moderate to severe obstructive sleep apnea in adults with obesity. Quote the current label for each product and have your clinician confirm it.
• Name the clinician with credentials and licensure.
• Show the process, including labs, monitoring, and follow-up.
• Use real local signals, including address, service area, hours, parking, and a map embed. Keep your name, address, and phone number consistent with your Google Business Profile.

The program page (Class C)

This page describes what supervised medical weight loss includes, in the order a patient experiences it. It is where the differentiation from the GLP-1 era playbook shows up: assessment, medication decisions, monitoring, nutrition and activity support, and a plan for after the medication.

The aftercare explainer (Class D)

Questions about stopping, plateaus, muscle, and maintenance come from people already on the drug or considering it. They match clinician authority well.

I leave the clinical content to your medical team. The marketing job is to commission the page, require sourcing, and put the clinician's name on it.

The pricing page (Class E)

In my experience patients ask about cost early, and a transparent pricing page can help conversion and extraction. The glossary entry on pricing pages explains the format. List what is included, what is billed separately, and what the clinician decides.

Compliance Lines on Page Copy

FDA and FTC rules apply to your site as well as your ads. Four lines matter most.

1. Compounded drugs are not FDA approved. FDA's page on unapproved GLP-1 drugs states that "compounded drugs are not FDA approved." It adds that they "should only be used in patients whose medical needs cannot be met by an FDA-approved drug."

2. Do not claim sameness. The same page lists a company that makes claims such as "the compounded drug is the same as an FDA-approved drug" as a red flag. Do not write it on a page, in a meta description, or in a heading.

3. Do not build pages around "research" products. FDA has warned companies selling semaglutide and tirzepatide labeled "for research purposes" or "not for human consumption."

4. Substantiate benefit claims and handle testimonials. The FTC's health products guidance requires competent and reliable scientific evidence for health benefit claims. It says testimonials with atypical results are likely deceptive, and that a results-not-typical disclaimer does not fix that.

Weight-loss testimonials sit squarely in that last warning. Show a typical result and say so, or skip the number.

Sourcing is a ranking and trust asset

Google's guidance on helpful, people-first content says E-E-A-T is not a ranking factor on its own and that trust carries the most weight among its components. It also says Google gives extra weight to topics that could significantly impact health. It recommends clear authorship, with bylines that link to information about the author.

On a medication page, that means four things.

• A named clinician as author, with credentials and a bio link.
• A named medical reviewer and a review date.
• Primary citations (FDA, labels, guidelines) in the body.
• Plain statements of risk and who should not use the medication.

The E-E-A-T glossary entry gives the background.

Build for the Questions AI Tools Split Your Keyword Into

Search tools that generate answers break a keyword into sub-questions and pull passages for each. That is called query fan-out. A "semaglutide weight loss" query splits into what it is, how it works, who qualifies, what it costs, side effects, what to expect, and what happens after.

A page that answers those sub-questions in clearly labeled sections is the page more likely to be quoted. Write each section to start with the answer, so a passage can stand alone. The answer-first writing entry covers the pattern.

Ranking and being cited are separate outcomes, so measure both. The AI search hub has the broader plan.

A Build Order

My software career included a platform that scaled from nothing to $500M, and the habit that stuck was building in dependency order. A clinic site has dependencies too, so here is the order I would use.

1. Fix the foundation. Google Business Profile, consistent name, address, and phone, and a crawlable site.
2. Publish one program page and one location page per location, with named clinicians and citations.
3. Add the eligibility content to each location page (Class B) with the current label language.
4. Publish three aftercare explainers (Class D) written or reviewed by your clinician.
5. Publish the pricing page (Class E).
6. Add a brand versus generic comparison that uses brand names accurately (Class A terms, used as entities).
7. Decide on compounded content with counsel before publishing anything (Class F).
8. Connect measurement. In Search Console, group queries by the six classes and track booked consultations.
9. Refresh quarterly, since this category's regulatory facts move.

Common Mistakes

• Building the site around brand-name drugs because they are famous.
• Publishing a compounded drug page that implies equivalence.
• Copying agency templates with no named author and no citations.
• Writing "semaglutide [city]" pages with no clinician, no process, and no pricing context.
• Ignoring Class D, the questions patients ask once they are on the medication.
• Measuring rankings instead of booked consultations.
• Letting facts go stale. FDA's GLP-1 page carries a current-as-of date for a reason, and your pages should too.

Your Next Step

This week, search your top three Class D questions in a private browser window and write down who ranks. Then change each Hypothesis in the table to confirmed or dropped before you commission a single page.

Questions practice owners ask

Should a weight loss clinic target "Ozempic" keywords?

Usually as supporting content only. The brand-name informational searches I checked return consumer health publishers and drug information sites. Use the brand name accurately inside comparison content and put your effort into local and aftercare classes.

What is the difference between Wegovy, Zepbound, and Ozempic on a clinic page?

Wegovy and Zepbound each carry FDA-approved indications for chronic weight management, and the current labels list additional indications. Read each product's current prescribing information before you write about it, and have your clinician review the page.

Can I write about compounded semaglutide?

FDA says compounded drugs are not FDA approved, and flags sameness claims. If you offer compounded medication, have counsel review the page, avoid equivalence language, and describe the clinical decision accurately.

How long until medical weight loss SEO works?

It depends on your market, site, and competitors. I do not promise a timeline. Track leading indicators such as indexed pages, impressions by class, and Google Business Profile actions, then booked consultations.

Do I need separate pages for each city?

Each physical location needs its own page. Pages for cities you do not serve add little value and can mislead patients.

How should reviews and testimonials appear on these pages?

Show reviews that are real and recent, and avoid specific weight numbers unless they reflect typical results, which follows the FTC's testimonial guidance on atypical results. See the online reviews glossary entry for handling.

Mike Kohl, founder of Health Biz Scale | Sources read October 28, 2026

This guide is general information, not medical, legal, or regulatory advice. Confirm medication and compounding rules with a qualified healthcare attorney before publishing.